A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea
Clinical trial NCT04546828 · WITHDRAWN
Trial details
- NCT number
- NCT04546828
- Sponsor
- Samsung Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2021-08-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.